Single answer
Is Aura Biosciences Inc (AURA) a buy or sell?
4starter turns market data into one clear verdict you can act on.
Create a free account to save tickers and track your signals.
Log in to turn on watchlist alerts.
What is the conclusion?
Right now our advanced algorithms say:
Do analysts agree?
We compare consensus targets with today's price.
Consensus target for Aura Biosciences Inc is $22.75, which is $17.26 (314.39%) above the current price today's price.
Low target: $19.00 | High target: $25.00
Company snapshot
A quick overview of the business and its public profile.
Aura Biosciences Inc operates as a biotechnology company that develops therapies to treat cancer The company develops viruslike drug conjugates VDC technology platform for the treat tumors of high unmet need in ocular and urologic oncology It develops AU011 a VDC candidate for the treatment of primary choroidal melanoma It also develops AU011 in additional ocular oncology indications including choroidal metastases The company was incorporated in 2009 and is headquartered in Cambridge Massachusetts
Website: https://www.aurabiosciences.com
Rates and inflation backdrop
US inflation for September 2025 was 0.31%. Over the last 12 months, inflation is 3.02%. The 10-year yield is 4.12 and is down -0.1000 over the last 30 days.
Inflation sensitivity
Debt ratio: 0.09. Cash flow to debt ratio: -4.60. Net profit margin: -8,188.85%. Inflation risk score: medium (0.70/1).
Dividend history check
We cannot find any recorded dividends paid in our systems.
Trading liquidity
Yes, the average daily trading liquidity for Aura Biosciences Inc is $1.4M. You should therefore be able to get in and out of your positions relatively fast.
10-year return check
We cannot find data for Aura Biosciences Inc 10 years ago, but if you had invested on 2021-10-29 when the price was $14.80, you would have made a loss of $9.31 per share or 62.91%.
Why this answer
We combine price momentum, volatility, and trend signals to simplify the decision to one word.
Signal engine scans price, trend, and momentum indicators.
Targets and sentiment are checked against the live quote.
We keep the output simple: buy, sell, or hold.
Analyst consensus
How Wall Street targets compare to today's price.